JB

Jane Bell

Mesoblast Limited | Non-Executive Director
Ms Bell is an experienced Chair and non-executive Director in regulated sectors including delivery of healthcare, life sciences, medical research, and funds management. She is a former Chair of Royal Melbourne Hospital and former Chair of Biomedical Research Victoria as well as Chair of Advisory Groups for the Royal Australian and New Zealand College of Obstetricians and Melbourne Genomics Health Alliance, a former director of Hudson Institute of Medical Research and director of U Ethical, Australia's first ethical funds manager. Ms Bell is a Member of the Order of Australia (AM), appointed for her service to governance in the medical research, healthcare and not-for-profit sectors. She is the member of the risk committee.

Companies and Roles

Company
Title
Tenure
Since
MSB
Mesoblast Limited
  • Non-Executive Director
4yrs, 1mthAug 2022
ATX
Amplia Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
5yrs, 6mthApr 2021

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
Mesoblast Limited
30/06/26N/A622,492719,037N/A
ATX
Amplia Therapeutics Limited
30/03/26485,0363,176,715762,329N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ATX
Amplia Therapeutics Limited
01/09/25
Issued
240,590$0.165$39,697Issue of options
ATX
Amplia Therapeutics Limited
01/09/25
Issued
130,435$0.230$30,000Placement
MSB
Mesoblast Limited
28/02/25
Buy
79,051$2.530$199,999On-market trade
MSB
Mesoblast Limited
09/01/25
Issued
192,308$2.810$540,385Issue of options
ATX
Amplia Therapeutics Limited
20/12/24
Issued
521,739$0.083$43,304As advised by the company